| |
| Magyar Diabetes Társaság |
|
| 2nd Annual World Congress on the Insulin Resistance Syndrome |
 Rendezvény kezdete: 2004.11.19. | Rendezvény vége: 2004.11.21. |
| Tudományos információ: Nava Mekel |
| Tel: +1-818-342-1889 |
| Fax: +1-818-342-1538 |
| E-mail: metabolicinst@pacbell.net or insulinresistance@pacbell.net |
| Helyszín: Los Angeles, Ca, USA |
The conference will focus on the world wide epidemic of the Insulin Resistance Syndrome and its prevalence in special population groups, women, and children. The program will cover the various fields which are part of the Insulin Resistance Syndrome including cardiovascular disease, PCOS, sleep apnea, hypertension, dyslipidemia, glucose intolerance, and endothelial dysfunction and will look into the emerging field of insulin resistance in liver disease and the development of certain cancers.
For more information: http://www.insulinresistance.us/ |
|
|
 |
| |
| Magyar Reumatológusok Egyesülete |
|
| 11th Brussels International Spine Symposium: Controversies in diagnosis, etiopathogenesis, management and costs |
| Rendezvény kezdete: 2004.11.19. | Rendezvény vége: 2004.11.20. |
| Fax: +32-3-239-6976 |
| Helyszín: Brussels, Belgium |
For more information or to register, contact: R. Gunzburg, MD, PhD at Eeuwfeestkliniek Antwerpen, Harmoniestraat 68, 2018, Antwerpen, Belgium.
|
|
|
|
| |
| Magyar Diabetes Társaság |
|
| 2nd Annual World Congress on the Insulin Resistance Syndrome |
| Rendezvény kezdete: 2004.11.19. | Rendezvény vége: 2004.11.21. |
| Tudományos információ: Nava Mekel |
| Tel: +1-818-342-1889 |
| Fax: +1-818-342-1538 |
| E-mail: metabolicinst@pacbell.net or insulinresistance@pacbell.net |
| Helyszín: Los Angeles, Ca, USA |
The conference will focus on the world wide epidemic of the Insulin Resistance Syndrome and its prevalence in special population groups, women, and children. The program will cover the various fields which are part of the Insulin Resistance Syndrome including cardiovascular disease, PCOS, sleep apnea, hypertension, dyslipidemia, glucose intolerance, and endothelial dysfunction and will look into the emerging field of insulin resistance in liver disease and the development of certain cancers.
For more information: http://www.insulinresistance.us/ |
|
|
|
